Cincinnati--The Women's Health Initiative (WHI) at the University of
Cincinnati announced today that the National Institutes of Health WHI
study of postmenopausal women will continue at the Cincinnati Clinical
Center, as well as the other 40 sites around the country. Margery Gass,
MD, is the principal investigator for the Cincinnati site.
the release of the information on the hormone replacement arm of the
study, there has been a lot of confusion," said Susie Sheridan, WHI
Program Director at UC. "Although women in the estrogen plus progestin
arm of the study have been told to stop taking their study pills, the
rest of the study continues." The Cincinnati WHI study has many facets,
including a hormone study of estrogen alone, involving 250 women, a
dietary program which has approximately 1,300 women, and an
observational study which tracks the health of 2,200 participants. All
of these programs continue.
In addition, the clinic will continue
to track the health of the women who have been in the estrogen plus
progestin arm of the study, who still need to have their annual exams
and mammograms. In a recent letter to the Cincinnati participants, Dr.
Gass wrote, "The questions we have answered about estrogen plus
progestin in 2002 were only possible because of your dedication to the
study. With your continued support and ongoing participation, we hope
to answer many more questions about women's health in the years to
For more information, call Sheridan at (513) 584-6064.